A Cross-over Study Examining the Bioequivalence of 3 Test Formulations to a Reference Formulation of Alectinib (RO5424802) in Healthy Volunteers

NCT02074553 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

97

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer

Interventions

DRUG: Ro542-4802/F03 (Reference)
DRUG: Ro542-4802/F07 (Test)
DRUG: Ro542-4802/F08 (Test)
DRUG: Ro542-4802/F14 (Test)

Sponsor

Hoffmann-La Roche